Form 8K IGC Pharma Inc For: 30 March
- Investing.com
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
IGC Pharma Inc (IGC)
IGC Pharma Inc stock price live, this page displays NYSE IGC stock exchange data. View the IGC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the IGC Pharma Inc real time stock price chart below.
What Is the IGC Pharma Inc Stock Price Today?
The IGC Pharma Inc stock price today is 0.3128.
What Is the Stock Symbol for IGC Pharma Inc?
The stock ticker symbol for IGC Pharma Inc is IGC.
Is IGC the Same as $IGC?
$IGC is a common way to refer to the IGC Pharma Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does IGC Pharma Inc Trade On?
IGC Pharma Inc is listed and trades on the NYSE stock exchange.
Is IGC Pharma Inc a Good Stock to Buy?
Determining whether IGC Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current IGC Pharma Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IGC quote. (ISIN: US45408X3089)
What Is the IGC Pharma Inc Stock Price Today?
The IGC Pharma Inc stock price today is 0.3128.
What Is the Stock Symbol for IGC Pharma Inc?
The stock ticker symbol for IGC Pharma Inc is IGC.
Is IGC the Same as $IGC?
$IGC is a common way to refer to the IGC Pharma Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does IGC Pharma Inc Trade On?
IGC Pharma Inc is listed and trades on the NYSE stock exchange.
Is IGC Pharma Inc a Good Stock to Buy?
Determining whether IGC Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current IGC Pharma Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IGC quote. (ISIN: US45408X3089)
0.3128
+0.0027(+0.87%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.3101
0.3130
52 wk Range
0.2420
0.4985
IGC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.31010.3130
52 wk Range
0.24200.4985
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IGC Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
4.1250
Upside
+1,218.73%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- Form 424B5 IGC Pharma Inc For: 6 January
- Investing.com
- 1
- Form 8K IGC Pharma Inc For: 30 March
- Investing.com
- Form 424B5 IGC Pharma Inc For: 6 January
- Investing.com
- 1
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer’s disease in the United States and Colombia. The company’s lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer’s. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer’s disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.
IGC Pharma Inc Earnings Call Summary for Q2/2026
- IGC Pharma renewed a $12M line of credit and divested a non-core facility, resulting in $1.1M non-cash profit and $600K annual expense reduction
- The company reported progress in its CALMA phase two Alzheimer's trial with expanded patient enrollment across U.S. and Canada sites
- Stock rose 2.74% in pre-market trading to $0.3678, showing investor optimism despite a previous 2.07% decline
- CEO Ram Mukunda forecasts completion of CALMA phase two trial by first half of 2027, emphasizing potential for early symptom reduction
- Company faces challenges with negative EPS forecasts but maintains focus on its MINT-AD AI platform for early Alzheimer's risk assessment
Last Updated: 11/17/2025, 11:57 AM
Read Full TranscriptCompare IGC to Peers and Sector
Metrics to compare | IGC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIGCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.7x | −5.4x | −0.5x | |
PEG Ratio | −0.08 | −0.59 | 0.00 | |
Price / Book | 3.7x | 3.4x | 2.6x | |
Price / LTM Sales | 27.1x | 5.6x | 3.2x | |
Upside (Analyst Target) | - | 44.5% | 47.6% | |
Fair Value Upside | Unlock | 6.6% | 6.1% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4.1250
(+1,218.73% Upside)
Earnings
Latest Release
Mar 19, 2026
EPS / Forecast
-0.01 / -0.02
Revenue / Forecast
300K / 262.5K
People Also Watch
FAQ
What Is the IGC Pharma (IGC) Stock Price Today?
The IGC Pharma stock price today is 0.3128 USD.
What Stock Exchange Does IGC Pharma Trade On?
IGC Pharma is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for IGC Pharma?
The stock symbol for IGC Pharma is "IGC."
What Is the IGC Pharma Market Cap?
As of today, IGC Pharma market cap is 29.9700M USD.
What Is IGC Pharma's Earnings Per Share (TTM)?
The IGC Pharma EPS (TTM) is -0.0780.
When Is the Next IGC Pharma Earnings Date?
IGC Pharma will release its next earnings report on Aug 12, 2026.
From a Technical Analysis Perspective, Is IGC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has IGC Pharma Stock Split?
IGC Pharma has split 1 times.
How Many Employees Does IGC Pharma Have?
IGC Pharma has 70 employees.
What is the current trading status of IGC Pharma (IGC)?
As of Apr 15, 2026, IGC Pharma (IGC) is trading at a price of 0.3128 USD, with a previous close of 0.3101 USD. The stock has fluctuated within a day range of 0.3101 USD to 0.3130 USD, while its 52-week range spans from 0.2420 USD to 0.4985 USD.
What Is IGC Pharma (IGC) Price Target According to Analysts?
The average 12-month price target for IGC Pharma is 4.1250 USD, with a high estimate of 5.25 USD and a low estimate of 3 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,218.73% Upside potential.
What Is the IGC Premarket Price?
IGC's last pre-market stock price is 0.3100 USD. The pre-market share volume is 11,130.0000, and the stock has decreased by -0.0001, or -0.0300%.
What Is the IGC After Hours Price?
IGC's last after hours stock price is 0.3134 USD, the stock has decreased by 0.0033, or 1.0600%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.